WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'5001 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 7'4181 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 45'530  45'803  46'050  46'267  46'461  49'057  51'659  49'974 
Births 495  498  498  494  487  402  672  758 
Surviving infants 489  492  492  488  481  396  660  742 
Pop. less than 5 years 2'589  2'567  2'423  2'354  2'255  2'139  3'637  3'727 
Pop. less than 15 years 6'523  6'487  6'399  6'457  6'511  8'570  11'137  10'771 
Female 15-49 years 11'446  11'637  11'825  11'950  12'057  12'765  12'365  12'776 

Number of reported case

(Click for retrospective incidence data for Ukraine)
Diphtheria 17  61  365  109 
Japanese encephalitis
Measles 12'746  1'333  39  48  817  6'841 
Mumps 799  955  951  1'985  26'538 
Pertussis 2'286  2'937  1'067  1'025  2'243  4'189 
Polio*
Rubella 1'952  3'667  2'333  3'495  37'931 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 23  12  13  17  36 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ukraine)
Vaccine year result method % card seen                                                
BCG          95  90  92  95  99 
DTP1          42  46  98  73 
DTP3          76  50  52  90  99 
HepB_BD          51  53  64  82 
HepB3          46  21  48  84 
Hib3          83  26  51  81 
JapEnc         
MCV          79  67  56  94  99 
MCV2          54  56  41  95  99 
PCV1         
PCV3         
Pol3          74  58  57  91  99 
Rota1         
Rota_last         
Rubella1          79  56  93 
TT2plus          41 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ukraine)
BCG 95  90  92  94  95  98 
DTP1 76  50  52  71  90  99 
DTP3 76  50  52  71  90  99 
HepB3 46  21  48  66  84 
Hib3 83  26  51  66  81 
MCV 79  67  56  75  94  99 
PCV3
Pol3 74  58  57  74  91  99 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; 7 years; Yes
DT 6 years; Yes
DTwP 3, 4, 5, 18 months; Yes
DTwPHibIPV 3, 4 months; Yes
HIB 18 months; Yes
HepB Birth; 1, 6 months; Yes
MMR 12 months; 6 years; Yes
OPV 5, 18 months; 6, 14 years; Yes
Td 14, 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes    No  Yes  No 
What years does the MYP cover? number 2009-2015  2009-2015  2009-2015      2007-2015  NA 
Nº of districts with microplans that include activities to raise immunization coverage number         490     

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR   No  No         

System performance

Total number of districts in country number         490  490  557 
Nº districts with DTP3 coverage >=80% number            
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes  Yes    Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes           

Finance

Percentage of routine vaccines funded by Government From 0 to 100%         100  100  99 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.